We found that other circulating thyroid-specific targets such as TPO, IYD, TG, and GFRA2 cfRNA fell accordingly post-treatment for thyroid cancer, and could be potential biomarkers to reflect thyroid mass. The gene discussed is GFRA2; the disease is thyroid gland carcinoma.